Page 982«..1020..981982983984..9901,000..»

Mental health issues must be tackled: NMP, Health News & Top Stories – The Straits Times

Posted: Published on March 5th, 2020

Should someone have to choose between food and mental health? This was the unfortunate dilemma faced by a person, known as Respondent #361, in a public consultation on mental health. Sharing the results in Parliament on Feb 26, Nominated MP Anthea Ong called for Medisave and MediShield Life to be extended equally to physical and mental health treatment Continue reading →

Posted in MS Treatment | Comments Off on Mental health issues must be tackled: NMP, Health News & Top Stories – The Straits Times

‘When I feel worried, I just have to believe in myself’: 14-year-old boy battles MS – KETV Omaha

Posted: Published on March 5th, 2020

Multiple sclerosis is a disease with no cure and the reality for one 14-year-old boy from Lincoln. Conner Root is still determined to enjoy life like any other kid his age.Conner is like most teenage boys. Continue reading →

Posted in MS Treatment | Comments Off on ‘When I feel worried, I just have to believe in myself’: 14-year-old boy battles MS – KETV Omaha

#ACTRIMS2020 Pregnancies and Menopause Affect Age of Progressive… – Multiple Sclerosis News Today

Posted: Published on March 5th, 2020

Women with multiple sclerosis (MS) who have never given birth and those who began menopause prematurely tend to develop progressive forms of the disease earlier, a study from theMayo Clinicsuggests. These findings were presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020, running through Saturday, Feb Continue reading →

Posted in MS Treatment | Comments Off on #ACTRIMS2020 Pregnancies and Menopause Affect Age of Progressive… – Multiple Sclerosis News Today

Primary Progressive Multiple Sclerosis Treatment Market Size Analysis and Growth (2020-2025) – News Times

Posted: Published on March 5th, 2020

Primary Progressive Multiple Sclerosis Treatment Market Latest Research Report 2020: The new report offers a powerful combination of latest, in-depth research studies on the Primary Progressive Multiple Sclerosis Treatment market. The authors of the report are highly experienced analysts and possess deep market knowledge. Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures): http://marketresearchbazaar.com/requestSample/15622 Major Players Analyzed Under This Report are: F. Continue reading →

Posted in MS Treatment | Comments Off on Primary Progressive Multiple Sclerosis Treatment Market Size Analysis and Growth (2020-2025) – News Times

9 Reasons to Stop Doing Your Own Taxes – The New York Times

Posted: Published on March 5th, 2020

Doing your own taxes really isnt like changing your own oil. Continue reading →

Posted in MS Treatment | Comments Off on 9 Reasons to Stop Doing Your Own Taxes – The New York Times

Ulcerative colitis involves these missing microbes – Futurity: Research News

Posted: Published on March 5th, 2020

Share this Article You are free to share this article under the Attribution 4.0 International license. Bacteria that normally inhabit healthy peoples intestinesand the anti-inflammatory metabolites these bacteria produceare depleted in ulcerative colitis patients, research finds. About 1 million people in the United States have ulcerative colitis, a serious disease of the colon with no cure. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Ulcerative colitis involves these missing microbes – Futurity: Research News

Telemedicine in the Management of Inflammatory Bowel Disease: An Updat | SHTT – Dove Medical Press

Posted: Published on March 5th, 2020

Sumona Bhattacharya,1 Uni Wong,2 Raymond K Cross2 1Digestive Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA; 2University of Maryland School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, Baltimore, MD, USA Correspondence: Raymond K Cross University of Maryland School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, 685 West Baltimore Street, Suite 8-00, Baltimore, MD 21201, USA Tel +1 410-706-3387 Fax +1 410-706-4330 Email rcross@som.umaryland.edu Abstract: Crohns disease and ulcerative colitis are the two most common subtypes of inflammatory bowel disease. Most studies show that this patient population is increasing in incidence. Patients with these diseases require lifelong care by experienced practitioners however the traditional medical model is not ideal for patients who require continuous close monitoring and whose symptoms may dramatically worsen between regularly scheduled visits. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Telemedicine in the Management of Inflammatory Bowel Disease: An Updat | SHTT – Dove Medical Press

IBD vs. IBS: What’s the difference? – CNET

Posted: Published on March 5th, 2020

IBS and IBD both cause some heavily unpleasant symptoms, but they are not the same condition. Irritable bowel syndrome, leaky gut, functional gut disorder Continue reading →

Posted in Ulcerative Colitis | Comments Off on IBD vs. IBS: What’s the difference? – CNET

Allergan and AbbVie Turn Eyes to the FTC for Approval of their $63 Billion Merger – BioSpace

Posted: Published on March 5th, 2020

AbbVie and Allergan have cleared a major hurdle in completing the merger of the two companies that began in June of 2019. On Tuesday, the European Commission gave the green light to the merger following the divestiture of an investigational autoimmune treatment. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Allergan and AbbVie Turn Eyes to the FTC for Approval of their $63 Billion Merger – BioSpace

Is Gilead Sciences the Best Buy in the Coronavirus Sell-Off? – Motley Fool

Posted: Published on March 5th, 2020

Fears over the SARS-CoV-2 virus, and a potential COVID-19 pandemic, are hurting the stock market. On Feb. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Is Gilead Sciences the Best Buy in the Coronavirus Sell-Off? – Motley Fool

Page 982«..1020..981982983984..9901,000..»